Electronic health records contain dispersed risk factor information that could be used to prevent breast and ovarian cancer - PubMed

Electronic health records contain dispersed risk factor information that could be used to prevent breast and ovarian cancer - PubMed

Electronic health records contain dispersed risk factor information that could be used to prevent breast and ovarian cancer

Thomas H Payne 1 2, Lue Ping Zhao 3, Calvin Le 1, Peter Wilcox 1, Troy Yi 1, Jesse Hinshaw 1, Duncan Hussey 1, Alex Kostrinsky-Thomas 4, Malika Hale 1, John Brimm 1, Fuki M Hisama 1 2

Affiliations 

• PMID: 32940694
 
• DOI: 10.1093/jamia/ocaa152

Abstract

Objective: The genetic testing for hereditary breast cancer that is most helpful in high-risk women is underused. Our objective was to quantify the risk factors for heritable breast and ovarian cancer contained in the electronic health record (EHR), to determine how many women meet national guidelines for referral to a cancer genetics professional but have no record of a referral.

Methods and materials: We reviewed EHR records of a random sample of women to determine the presence and location of risk-factor information meeting National Comprehensive Cancer Network (NCCN) guidelines for a further genetic risk evaluation for breast and/or ovarian cancer, and determine whether the women were referred for such an evaluation.

Results: A thorough review of the EHR records of 299 women revealed that 24 (8%) met the NCCN criteria for referral for a further genetic risk evaluation; of these, 12 (50%) had no referral to a medical genetics clinic.

Conclusions: Half of the women whose EHR records contain risk-factor information meeting the criteria for further genetic risk evaluation for heritable forms of breast and ovarian cancer were not referred.

Keywords: electronic health records; genetics; oncology.

© The Author(s) 2020. Published by Oxford University Press on behalf of the American Medical Informatics Association.

Similar articles

• Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.

  Febbraro T, Robison K, Wilbur JS, Laprise J, Bregar A, Lopes V, Legare R, Stuckey A.Gynecol Oncol. 2015 Jul;138(1):109-14. doi: 10.1016/j.ygyno.2015.04.029. Epub 2015 Apr 28.PMID: 25933682 Free PMC article.
• Evaluating the performance of National Comprehensive Cancer Network (NCCN) breast and ovarian genetic/familial high risk assessment referral criteria for breast cancer women in an Asian surgical breast clinic.

  Lim GH, Borje E, Allen JC Jr.Gland Surg. 2017 Feb;6(1):35-42. doi: 10.21037/gs.2016.11.05.PMID: 28210550 Free PMC article.
• Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.

  Stuckey A, Febbraro T, Laprise J, Wilbur JS, Lopes V, Robison K.Am J Clin Oncol. 2016 Aug;39(4):363-7. doi: 10.1097/COC.0000000000000073.PMID: 24710121
• Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility [Internet].

  Nelson HD, Huffman LH, Fu R, Harris EL, Walker M, Bougatsos C.Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Sep.PMID: 20722133 Free Books & Documents. Review.
• Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.

  Wilson BJ, Torrance N, Mollison J, Wordsworth S, Gray JR, Haites NE, Grant A, Campbell MK, Miedyzbrodzka Z, Clarke A, Watson MS, Douglas A.Health Technol Assess. 2005 Feb;9(3):iii-iv, 1-126. doi: 10.3310/hta9030.PMID: 15694064 Review.